We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
-4.07%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$8.61B
AUM Growth
-$1.09B
Cap. Flow
-$352M
Cap. Flow %
-4.08%
Top 10 Hldgs %
30.78%
Holding
207
New
16
Increased
51
Reduced
80
Closed
30

Top Buys

Rank Stock Value
1
OM icon
Outset Medical
OM
+$58.4M
2
BSX icon
Boston Scientific
BSX
+$41.2M
3
PACB icon
Pacific Biosciences
PACB
+$38.3M
4
AUPH icon
Aurinia Pharmaceuticals
AUPH
+$37.2M
5
CDNA icon
CareDx
CDNA
+$32.9M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$109M
2
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
+$75.3M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$73.9M
4
DHR icon
Danaher
DHR
+$66.3M
5
HUM icon
Humana
HUM
+$65.4M

Sector Composition

Rank Sector Weight
1 Healthcare 98.39%
2 Industrials 0.69%
3 Energy 0.03%
4 Technology 0.01%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRVA icon
101
Privia Health
PRVA
$3.31B
$14M 0.16%
525,000
– –
GH icon
102
Guardant Health
GH
$19.6B
$13.9M 0.16%
209,712
-83,900
-29% -$5.74M
AMGN icon
103
Amgen
AMGN
$197B
$13M 0.15%
53,800
-4,350
-7% -$999K
HCAT icon
104
Health Catalyst
HCAT
$160M
$11.1M 0.13%
424,611
-268,055
-39% -$7.61M
PRCT icon
105
Procept Biorobotics
PRCT
$1.09B
$10M 0.12%
286,075
+112,426
+65% +$2.71M
ONEM
106
DELISTED
1Life Healthcare
ONEM
$9.27M 0.11%
836,190
– –
WVE icon
107
Wave Life Sciences
WVE
$1.1B
$9.13M 0.11%
4,562,858
-40,000
-0.9% -$98K
BDTX icon
108
Black Diamond Therapeutics
BDTX
$104M
$9.12M 0.11%
3,293,000
-170,000
-5% -$621K
XRAY icon
109
Dentsply Sirona
XRAY
$2.7B
$7.83M 0.09%
159,129
– –
AMWL icon
110
American Well
AMWL
$210M
$7.45M 0.09%
88,485
-17,907
-17% -$1.51M
SGEN
111
DELISTED
Seagen Inc. Common Stock
SGEN
$7.26M 0.08%
50,400
+4,400
+10% +$595K
HRMY icon
112
Harmony Biosciences
HRMY
$1.94B
$6.08M 0.07%
124,961
+3,800
+3% +$155K
AZN icon
113
AstraZeneca
AZN
$255B
$5.94M 0.07%
44,800
+15,300
+52% +$1.83M
BMRN icon
114
BioMarin Pharmaceuticals
BMRN
$11.4B
$5.75M 0.07%
74,600
+3,200
+4% +$268K
QTTB icon
115
Q32 Bio
QTTB
$346M
$5.01M 0.06%
91,507
-5,000
-5% -$311K
GILD icon
116
Gilead Sciences
GILD
$165B
$4.96M 0.06%
83,450
-73,550
-47% -$4.7M
JNJ icon
117
Johnson & Johnson
JNJ
$599B
$4.91M 0.06%
27,700
+7,500
+37% +$1.28M
BIIB icon
118
Biogen
BIIB
$29.5B
$4.71M 0.05%
22,350
-502,650
-96% -$109M
BHVN
119
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$4.65M 0.05%
39,207
+1,200
+3% +$150K
LUNG icon
120
Pulmonx
LUNG
$57M
$4.38M 0.05%
176,510
– –
DOCS icon
121
Doximity
DOCS
$3.91B
$4.32M 0.05%
+82,860
New +$4.17M
NPCE icon
122
Neuropace
NPCE
$537M
$4.17M 0.05%
507,930
– –
OLK
123
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$4.16M 0.05%
235,273
– –
BNR
124
Burning Rock Biotech
BNR
$106M
$4.08M 0.05%
43,887
-5,102
-10% -$443K
RCUS icon
125
Arcus Biosciences
RCUS
$3.54B
$3.52M 0.04%
111,700
+24,200
+28% +$811K
3 4
5
6 7

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q1 2022 Portfolio in Review

As of Q1 2022, Bellevue Group held 207 positions worth $8.61B, down 11% from $9.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bellevue Group withdrew a net $352M in Q1 2022, closing 30 positions and reducing 80 holdings. Its most notable exit was VOCERA COMMUNICATIONS, INC., an estimated $75.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 98% a quarter earlier, followed by Industrials and Energy.

Against the trend, Bellevue Group opened a new position in Aurinia Pharmaceuticals worth $29.8M.

  • Bellevue Group's largest Q1 2022 buy was Aurinia Pharmaceuticals: 2,405,825 shares worth $29.8M.
  • Bellevue Group added most to Outset Medical in Q1 2022, an estimated $58.4M increase.
  • Bellevue Group's biggest Q1 2022 reduction was Biogen, cutting an estimated $109M.
  • Bellevue Group fully exited VOCERA COMMUNICATIONS, INC. in Q1 2022, selling an estimated $75.3M.
  • Bellevue Group's ten largest holdings make up 31% of its $8.61B portfolio in Q1 2022.
  • Bellevue Group opened 16 new positions and closed 30 in Q1 2022.
  • Bellevue Group's portfolio value fell 11% quarter-over-quarter to $8.61B.

Based on Bellevue Group's 13F filing for Q1 2022, filed 13 May 2022.